ID   Relicell hES1
AC   CVCL_B362
SY   ReliCellhES1; Rel Cell hES 271204 p32 NSO Col; DALCe001-A
DR   hPSCreg; DALCe001-A
DR   ISCR; 1664
DR   SKIP; SKIP002160
DR   Wikidata; Q54949720
RX   Patent=US7811817;
RX   PubMed=16533307;
RX   PubMed=16919167;
WW   https://web.archive.org/web/20180602015113/http://www.rellife.com/rm_cellsresearch.html
CC   Group: Patented cell line.
CC   From: Reliance Life Sciences, Ltd; Navi Mumbai; India.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8172.
CC   HLA typing: A*01:02; B*56:01,35; C*01:04; DQB1*05; DRB1*01,01 (PubMed=16919167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16533307; PubMed=16919167
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 17
//
RX   Patent=US7811817;
RA   Mandal A., Tipnis S., Ravindran G., Kulkarni J., Patki A., Pal R.,
RA   Bose B., Kahn A.F., Khanna A.;
RT   "Establishment of a human embryonic stem cell line using mammalian
RT   cells.";
RL   Patent number US7811817, 12-Oct-2010.
//
RX   PubMed=16533307; DOI=10.1111/j.1432-0436.2006.00051.x;
RA   Mandal A., Tipnis S., Pal R., Ravindran G., Bose B., Patki A.,
RA   Rao M.S., Khanna A.;
RT   "Characterization and in vitro differentiation potential of a new
RT   human embryonic stem cell line, ReliCellhES1.";
RL   Differentiation 74:81-90(2006).
//
RX   PubMed=16919167; DOI=10.1186/1741-7007-4-28;
RA   Josephson R., Sykes G.R., Liu Y., Ording C.J., Xu W.-N., Zeng X.-M.,
RA   Shin S., Loring J.F., Maitra A., Rao M.S., Auerbach J.M.;
RT   "A molecular scheme for improved characterization of human embryonic
RT   stem cell lines.";
RL   BMC Biol. 4:28.1-28.13(2006).
//